Founding Member and Chief of Research and Development at xNARA Secures $150 Million Funding for Clinical Trial Advancements
In efforts to advance scientific research within the health and wellness industry, Dr. Rafi Ahmad, a Norwegian scientist and visionary leader for xNARA, a company known for tailoring supplements based on DNA, gut microbiome, and lifestyle, recently reached a remarkable milestone in raising $150 million for clinical trials and research in the fields of Biotechnology, Gut Microbial Sciences, and Preventative Wellness.
Dr. Ahmad’s dedication and commitment to advancing the future of scientific research and innovation have been instrumental in propelling xNARA’s unique approach to personalized wellness solutions. It has also set a precedent for the entire scientific community.
He received his Master’s of Science in Bioinformatics from University of Exeter and then proceeded to earn a Ph.D. in Bioinformatics and Computational Chemistry in Norway. His extensive educational background served as a strong foundation for his future achievements, including his valuable contributions to xNARA.
Garnering a reputation as a respected thought leader, Dr. Ahmad has held prominent positions at well-regarded organizations such as AstraZeneca, Dassault Systemes, and Medivir. Notably, under Dr. Ahmad’s guidance, a groundbreaking new drug is set to enter the U.S. Food and Drug Administration (FDA) clinical trials in 2023, promising advancements in chronic disease treatment.
The exceptional ability demonstrated by Dr. Ahmad to secure research funding has recently yielded impressive results, including the acquisition of $150 million in funding. Additionally, his success extended to securing support from the Research Council of Norway for a collaborative project aimed at tackling persistent health and microbial challenges. His expertise ultimately led to a nomination to represent Norway on the European Union scientific advisory committee, resulting in the development of three patents in immunological health and advanced disease treatment.
From advanced drug development to securing research funding, Dr. Ahmad’s achievements significantly contribute to xNARA’s leadership in the field. His extraordinary journey exemplifies dedication, serving as a key component to the company’s ongoing research and innovations.
With inspiration stemming from Dr. Ahmad’s success, xNARA has created a distinguished scientific advisory committee, featuring Dr. Ahmad along with esteemed individuals like Harvard professors and authors such as Dr. Uma Naidoo, and the Chairman of the American Health Association and integrated medicine professor, Dr. Kenneth Pelletier. Having established thought leaders who embody such determination and expertise, the company is set to excel in its ongoing research pursuits.
For more information, please visit https://www.xnara.com/.
About xNARA
xNARA is revolutionizing the world of supplements through personalized solutions. Understanding that one-size-fits-all approaches don’t yield desired results, they created Complements—a line of tailored supplements that address individual needs and goals with scientific precision. Each formula is meticulously crafted based on an in-depth analysis of clients lifestyle, biology, and overall health, ensuring optimal effectiveness. With a selection of 125 highly-active Swiss-sourced ingredients, including concentrated vitamins, minerals, amino acids, pro and prebiotics, bioactive compounds, and herbal extracts, they provide the right dosage for your body to experience true impact. Their commitment to personalized health extends to affordability and convenience—replacing multiple pills with just two sachets per day. Experience the power of customization and maximize your well-being with Complements from xNARA.
Media Contact
Company Name: Otter PR
Contact Person: Gabrielle Lask
Email: Send Email
City: Orlando
State: Florida
Country: United States
Website: OtterPR.com
